Affiliation:
1. Department of Health Promotion and Behavioral Sciences, University of Texas School of Public Health, Houston, TX 77030, USA
2. Department of Anthropology, Washington University in St. Louis, St. Louis, MO 63130, USA
3. Department of Pediatrics, Infectious Diseases Section, Baylor College of Medicine, Houston, TX 77030, USA
Abstract
Human papilloma virus (HPV) vaccination rates remain below national goals in the United States despite the availability of evidence-based strategies to increase rates. The Adolescent Vaccination Program (AVP) is a multi-component intervention demonstrated to increase HPV vaccination rates in pediatric clinics through the implementation of six evidence-based strategies. The purpose of this study, conducted in Houston, Texas, from 2019–2021, was to adapt the AVP into an online decision support implementation tool for standalone use and to evaluate its feasibility for use in community clinics. Phase 1 (Adaptation) comprised clinic interviews (n = 23), literature review, Adolescent Vaccination Program Implementation Tool (AVP-IT) design documentation, and AVP-IT development. Phase 2 (Evaluation) comprised usability testing with healthcare providers (HCPs) (n = 5) and feasibility testing in community-based clinics (n = 2). AVP-IT decision support provides an Action Plan with tailored guidance on implementing six evidence-based strategies (immunization champions, assessment and feedback, continuing education, provider prompts, parent reminders, and parent education). HCPs rated the AVP-IT as acceptable, credible, easy, helpful, impactful, and appealing (≥80% agreement). They rated AVP-IT supported implementation as easier and more effective compared to usual practice (p ≤ 0.05). The clinic-based AVP-IT uses facilitated strategy implementation by 3-month follow-up. The AVP-IT promises accessible, utilitarian, and scalable decision support on strategies to increase HPV vaccination rates in pediatric clinic settings. Further feasibility and efficacy testing is indicated.
Funder
Cancer Prevention and Research Institute of Texas
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference58 articles.
1. Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2008;Satterwhite;Sex. Transm. Dis.,2013
2. US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines;Saraiya;J. Natl. Cancer Inst.,2015
3. Human Papillomavirus-Associated Cancers—United States, 2008–2012;Viens;MMWR Morb. Mortal. Wkly. Rep.,2016
4. Human papillomavirus and rising oropharyngeal cancer incidence in the United States;Chaturvedi;J. Clin. Oncol.,2011
5. Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973–2000;Johnson;Cancer,2004
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献